Skip to content

Clinical trials

Immune Reconstitution Inflammatory Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune Reconstitution Inflammatory Syndrome Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20122
20133
20142
20151
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Assistance Publique - Hôpitaux de Paris1
Biogen1
Fondation Ophtalmologique Adolphe de Rothschild1
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1
National Institute of Cancerología1
National Institute of Neurological Disorders and Stroke (NINDS)1
University Hospital, Basel, Switzerland1
University of Cape Town1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune Reconstitution Inflammatory Syndrome14
Acquired Immunodeficiency Syndrome6
Tuberculosis4
Leukoencephalopathy, Progressive Multifocal3
Opportunistic Infections2
Encephalitis1
Genetic Predisposition to Disease1
HIV Infections1
Hematologic Neoplasms1
Infections1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.